SHH and medulloblastoma: Blocking the pathway by small molecules inhibitors of the GTP-binding protein-coupled receptor Smoothened (Smo) is proposed as an alternative for treating Shh-dependent medulloblastoma, a cerebellar tumor with a poor prognosis in children (Ruat et al. 2014; Swiderska-Syn et al. 2022).